Data as of 4:00pm ET
| -0.11 / -3.59%|
The 1 analysts offering 12-month price forecasts for Biota Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +69.49% increase from the last price of 2.95.
The current consensus among 1 polled investment analysts is to Buy stock in Biota Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.